Sucampo Pharmaceuticals' P2P Acquisition

Sucampo Pharmaceuticals raised a round of funding on February 14, 2018. Investors include Mallinckrodt.

Sucampo Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of highly specialized medicines.…

Articles about Sucampo Pharmaceuticals' P2P Acquisition: